Gene Silencing Market Growth Outlook Reveals A CAGR Of 12.6% And A Market Value Of $12.09 Billion By 2030
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Gene Silencing Market Forecast: What Market Value Is Expected By 2030?
The gene silencing market has seen swift expansion in recent years, climbing from $6.69 billion in 2025 to an expected $7.53 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.5%. This historical upward trajectory is driven by progress in molecular biology research, the uncovering of RNA interference pathways, a rise in academic research financing, a surge in genetic disorder investigations, and greater investment in pharmaceutical research and development.
The gene silencing market is projected to experience robust expansion in the coming years, with its value anticipated to reach $12.1 billion by 2030, driven by a compound annual growth rate (CAGR) of 12.6%. Several key factors are fueling this upward trajectory during the forecast period, including the expansion of gene therapy pipelines, a heightened demand for targeted therapeutic approaches, broader applications of CRISPR technology, an upsurge in clinical trial activities, and the emergence of next-generation gene editing tools. Notable trends shaping this period encompass the increasing utilization of RNA interference technologies, the growing adoption of CRISPR-based methods for gene silencing, the broadening of therapeutic gene targeting initiatives, a heightened emphasis on precision medicine applications, and a marked rise in investments dedicated to these innovative approaches.
Download A Free Sample Report For Comprehensive Market Insights:
#Gene Silencing Market Growth Factors: Which Forces Are Supporting Market Expansion?
The increasing occurrence of genetic disorders is forecasted to drive forward the expansion of the gene silencing market. These disorders are defined as health issues resulting from DNA abnormalities and are being detected more frequently due to improvements in diagnostic methods, greater public awareness, and expanded availability of genetic screening. The rise in such conditions is attributed to growing parental age, which increases the likelihood of transmitting genetic mutations to children. Gene silencing provides a viable strategy for addressing these disorders by specifically deactivating the expression of defective or disease-causing genes. For example, in August 2023, Down Syndrome UK, a charity based in the United Kingdom, reported that approximately 40,000 individuals in the UK are affected by Down syndrome, with about 1 in every 800 newborns diagnosed with the condition. As a result, the rising prevalence of genetic disorders is fueling growth in the gene silencing market.
Gene Silencing Market Segmentation: How Is The Market Structured Across Key Categories?
The gene silencing market covered in this report is segmented –
1) By Type: Transcriptional, Post-Transcriptional, Meiotic
2) By Gene Silencing: RNA Interference (RNAi), Antisense Oligonucleotides (ASOs), Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Or Cas9 -Based Gene Silencing, Other Gene Silencings
3) By Application: Neurology, Oncology, Infectious Diseases, Metabolic Diseases, Therapeutics Manufacturing, Other Applications
4) By End-Users: Pharmaceutical And Biotechnology Companies, Research Institutes and Academic Centers, Hospitals, Clinics, Other End-Users
Subsegments:
1) By Transcriptional: DNA Methylation, Histone Modification
2) By Post-Transcriptional: RNA Interference (RNAi), Antisense Oligonucleotides, MicroRNA (miRNA) Mediated Silencing
3) By Meiotic: Meiotic Gene Conversion, Transposable Element Silencing
Gene Silencing Market Industry Trends: What Changes Are Reshaping Demand?
Key players within the gene silencing market are concentrating on the creation of advanced technologies, including small interfering RNA (siRNA), aimed at improving both precision and effectiveness in gene therapy. SiRNA is a type of RNA molecule essential to the RNA interference (RNAi) pathway; it operates by attaching to specific messenger RNA (mRNA) and facilitating its breakdown, thereby stopping the generation of proteins that lead to disease. A case in point occurred in October 2024, when Judo Bio Inc., a biotechnology firm headquartered in the United States, unveiled an siRNA-based next-generation drug designed to silence genes. This innovation is distinguished by proprietary delivery mechanisms, such as lipid nanoparticles or conjugated ligands, which guarantee targeted absorption by particular cells or tissues, alongside AI-powered platforms that speed up the discovery of viable gene targets.
Gene Silencing Market Competitive Landscape And Leading Companies
Major companies operating in the gene silencing market are Roche Holding AG, Merck & Co. Inc., AstraZeneca plc, Novartis International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Alnylam Pharmaceuticals Inc., GenScript Biotech Corporation, Oxford BioMedica plc, Ionis Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., New England Biolabs Inc., Quark Pharmaceuticals Inc., Sirion Biotech GmbH, Benitec Biopharma Limited, GeneCopoeia Inc., Revvity Inc.
Access The Complete Gene Silencing Market Report:
Gene Silencing Market Geographic Distribution And Regional Opportunities
North America was the largest region in the gene silencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene silencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
